(Reuters) – Johnson & Johnson late last year quietly shut down the only plant making usable batches of its COVID-19 vaccine, the New York Times reported, citing people familiar with the decision.
The halt is temporary, with the Leiden plant expected to start making the vaccine again after a pause of a few months, the NYT report said. The NYT report added that it was not clear whether the pause has had an impact on vaccine supplies yet, thanks to stockpiles.
The company did not immediately respond to a Reuters request for comment.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Anil D’Silva)
